Last reviewed · How we verify

NCT03100851

Effect of Probiotic on Constipation

Completed Phase 3 Last updated 29 June 2017
What this trial tests

Phase 3 trial testing Lactobacillus casei strain Shirota in Constipation in 62 participants. Completed in 17 March 2017.

Timeline
2 August 2015
Primary endpoint
26 September 2016
17 March 2017

Quick facts

Lead sponsorChina Agricultural University
PhasePhase 3
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment62
Start date2 August 2015
Primary completion26 September 2016
Estimated completion17 March 2017

Drugs / interventions tested

Conditions studied

Sponsor

China Agricultural University

Who can join

Adults 18 to 45, any sex, with Constipation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Constipation is a prevalent intestinal disorder. Lactobacillus casei strain Shirota (LcS) shows potential effect on alleviating constipation. This study evaluated the impact of fermented milk containing LcS on stool consistency and frequency. The stool short chain fatty acid and gut microbiota were also assessed.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Lactobacillus casei strain Shirota

Trials testing the same drug.

Other recruiting trials for Constipation

Currently open trials in the same condition.

Other China Agricultural University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03100851.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing